© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 14, 1248-1249,
July 21, 1999
© 1999 Oxford University Press
BOOK REVIEW |
Recent Results in Cancer Research: Assessing the Economic Value of Anticancer Therapies
Niels Neymark. Berlin (Germany): Springer-Verlag, 1998. 285 pp., illus. $109. ISBN 3-540-64030-4
Affiliation of author: Division of Cancer Control and Population Science, National Cancer Institute, Bethesda, MD.
Correspondence to: Kevin B. Knopf, M.D., M.P.H., National Institutes of Health, Executive Plaza North, Rm. 313, MSC 7344, Bethesda, MD 20892-7344.
The need for accurate economic analysis to guide health care delivery is irrefutable, since
health care costs continue to rise in parallel with a growing demand in value for our spending.
Cancer care accounts for 5%-10% of all health care dollars spent in the United
States, and although breakthroughs in cancer research will provide much needed improvements
in the treatment of cancer, they will also come at a cost. Dr. Neymark speaks in his preface of the
"aura of sanctity" surrounding cancer so that "everything possible"
is done for the patients. This aura derives partly from the seriousness of the